Physician profile
John W Kish
NPI 1275537979
$1,536.98
in general payments reported to CMS, 2019-2025
9 companies · $186 in 2025
The $186 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $227 · 2020: $149 · 2021: $142 · 2022: $413 · 2023: $133 · 2024: $285 · 2025: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $605.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $604.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $495.18 | 2021-2025 | Spyglass Discover, Embold Fibered |
| Medtronic USA, INC. | $202.79 | 2019 | |
| Stryker Corporation | $191.17 | 2023-2025 | Flowtriever, Eikon Lt Adapt Smoke Evacuation, Photonblade |
| Penumbra, INC. | $173.99 | 2020-2022 | |
| Cook Medical LLC | $173.06 | 2022-2023 | Cook |
| Inari Medical, INC. | $126.55 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Angiodynamics, INC. | $125.06 | 2022 | |
| Biocompatibles, INC. | $24.67 | 2019 | |
| Terumo Medical Corporation | $24.51 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Kish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.